Drug recall · July 16, 2014
Heparin Sodium in 5% Dextrose Injection recall
Why: Lack of Assurance of Sterility: Confirmed consumer report of fluid leaking from primary container of bag.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium in 5% Dextrose Injection, Heparin, 25,000 USP Heparin Units/250 mL (100 USP Heparin Units/mL), 250 mL, Single-Dose Container, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-7793-62
- Lots / codes
Lot # 34-811-KL, 36-106-KL, 36-114-KL; Exp. 12/15; 36-101-KL, Exp. 12/15; 37-202-KL, Exp. 1/16; 38-302-KL, Exp. 2/16; 38-305-KL, Exp. 2/16
- Quantity
- 142,152 bags
- Company
- Hospira Inc., Lake Forest, IL
- Distribution
- Nationwide
- Initiated
- June 6, 2014 · Voluntary: Firm initiated
- Classified
- July 9, 2014
- Reported
- July 16, 2014
- Ended
- April 3, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.